These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4202888)

  • 1. Release of beta-lysin from platelets by thrombin and by a factor produced in heparinized blood.
    Tew JG; Roberts RR; Donaldson DM
    Infect Immun; 1974 Jan; 9(1):179-86. PubMed ID: 4202888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of beta-lysin from platelets caused by antigen-antibody complexes, purified enzymes, and platelet-aggregating substances.
    Roberts RR; Tew JG; Donaldson DM
    Infect Immun; 1977 Feb; 15(2):485-90. PubMed ID: 844904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLASMA COAGULATION BY ORGANISMS OTHER THAN STAPHYLOCOCCUS AUREUS.
    BAYLISS BG; HALL ER
    J Bacteriol; 1965 Jan; 89(1):101-5. PubMed ID: 14255647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation.
    Badimon L; Badimon JJ; Lassila R; Heras M; Chesebro JH; Fuster V
    Blood; 1991 Jul; 78(2):423-34. PubMed ID: 2070078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
    Hidaka H; Asano T
    J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing techniques: the use of recalcified plasma in comparison with citrated plasma alone and in combination with thrombin in ultrastructural studies.
    Pretorius E; Oberholzer HM; van der Spuy WJ; Franz RC
    Hematology; 2011 Nov; 16(6):337-40. PubMed ID: 22183067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcium on the availability of platelet von Willebrand factor.
    Parker RI; Rick ME; Gralnick HR
    J Lab Clin Med; 1985 Sep; 106(3):336-42. PubMed ID: 3161964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.
    Droller MJ; Wolfe SM
    J Clin Invest; 1972 Dec; 51(12):3094-103. PubMed ID: 4344994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of heparin and citrate on platelet aggregation.
    O'Brien JR; Shoobridge SM; Finch WJ
    J Clin Pathol; 1969 Jan; 22(1):28-31. PubMed ID: 5784692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on plasma factor involved in 5-hydroxytryptamine release from blood platelets by bacterial endotoxin. 3. Mechanism of action of 5-hydroxytryptamine releasing factor.
    Nomura Y; Okada T; Takagi H
    Jpn J Pharmacol; 1972 Feb; 22(1):79-87. PubMed ID: 4537627
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin, platelets and blood coagulation: implications for low-dose heparin prophylactic regimens in venous thrombosis.
    Han P; Ardlie NG
    Br J Haematol; 1974 Jun; 27(2):253-72. PubMed ID: 4843673
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of heparin on the early stages of blood coagulation.
    O'BRIEN JR
    J Clin Pathol; 1960 Mar; 13(2):93-8. PubMed ID: 14428016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of platelet-derived β-thromboglobulins on coagulation.
    Egan K; van Geffen JP; Ma H; Kevane B; Lennon A; Allen S; Neary E; Parsons M; Maguire P; Wynne K; O' Kennedy R; Heemskerk JWM; Áinle FN
    Thromb Res; 2017 Jun; 154():7-15. PubMed ID: 28384443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation.
    Ponert JM; Schwarz S; Haschemi R; Müller J; Pötzsch B; Bendas G; Schlesinger M
    PLoS One; 2018; 13(1):e0191303. PubMed ID: 29346400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
    Lau LF; Pumiglia K; Côté YP; Feinstein MB
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Ca2+ and protein phosphorylation in the rabbit platelet release reaction.
    Lyons RM; Shaw JO
    J Clin Invest; 1980 Feb; 65(2):242-55. PubMed ID: 6985917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy.
    Ahnadi CE; Sabrinah Chapman E; Lépine M; Okrongly D; Pujol-Moix N; Hernández A; Boughrassa F; Grant AM
    Thromb Haemost; 2003 Nov; 90(5):940-8. PubMed ID: 14597991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the phosphoinositide hydrolysis pathway in thrombin-stimulated platelets by a pertussis toxin-sensitive guanine nucleotide-binding protein. Evaluation of its contribution to platelet activation and comparisons with the adenylate cyclase inhibitory protein, Gi.
    Brass LF; Laposata M; Banga HS; Rittenhouse SE
    J Biol Chem; 1986 Dec; 261(36):16838-47. PubMed ID: 3023367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compounds known to affect the cyclic adenosine monophosphate level in blood platelets: effect on thrombin-induced clot retraction and platelet release.
    Mürer EH
    Biochim Biophys Acta; 1971 May; 237(2):310-5. PubMed ID: 4328395
    [No Abstract]   [Full Text] [Related]  

  • 20. Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin?
    Rota S; Flynn PD; Wareham NJ; Baglin TP; Byrne CD
    Thromb Res; 1996 Aug; 83(4):329-38. PubMed ID: 8870177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.